Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Gleevec (generic name: imatinib mesylate) is an oral targeted therapy medication used to treat specific types of cancer, most notably chronic myelogenous leukemia (CML) and certain gastrointestinal stromal tumors (GIST). It works by blocking abnormal tyrosine kinase proteins that signal cancer cells to grow and multiply.
Gleevec (generic name: imatinib mesylate) is an oral targeted therapy medication used to treat specific types of cancer, most notably chronic myelogenous leukemia (CML) and certain gastrointestinal stromal tumors (GIST). It works by blocking abnormal tyrosine kinase proteins that signal cancer cells to grow and multiply.